Prevalence of Hepatitis C Virus Infection among People Living with HIV/AIDS Attending Specialist Hospital Sokoto, Nigeria
DOI:
https://doi.org/10.47430/ujmr.2493.029Keywords:
Hepatitis C, HIV, AIDS, Seroprevalence, Risk factors, SokotoAbstract
Study’s Novelty/Excerpt
- This study assesses HIV/HCV coinfection and associated risk factors among patients at Specialist Hospital, Sokoto, highlighting the seroprevalence of HCV among HIV/AIDS reactive individuals.
- The novelty lies in its detailed demographic analysis, revealing significant age, gender, tribal, educational, and occupational disparities, with a notably high seropositivity among people who inject drugs.
- These findings underscore the necessity for targeted HCV screening and intervention strategies in HIV/AIDS patients, particularly in demographic subgroups identified as having higher seroprevalence, to improve early diagnosis and management.
Full Abstract
The Hepatitis C virus (HCV) remains a large healthcare burden. Human Immunodeficiency Virus (HIV) and HCV coinfection are major global health concerns worldwide. This study aimed to assess the HIV/HCV coinfection and the potential risk factors among people attending Specialist Hospital, Sokoto. A cross-sectional seroprevalence survey of HCV infection was carried out on 77 HIV/AIDS reactive subjects attending Specialist Hospital, Sokoto, from 30th March 2021 to 4th May 2021. Serum samples were tested for anti-HCV antibodies using immunochromatographic test. Of the 77 study participants, the overall anti-HCV antibody prevalence was 5.2%. The 36-40 age group revealed the highest seropositivity of 18.18%, followed by 51-55 years (14.29%) and the least (11.11%) among 26-30 years. Females had the highest seropositivity of 6.25% and males least (3.45%). The highest seropositivity was seen among the Hausa tribe (7.14%), while the least in Fulani (5.56%). The highest seropositivity was recorded among people with no formal education (6.82%), while people with formal education had the least (5.88%). The highest seropositivity was seen in self-employed individuals (6.52%) regarding occupational status, while employed individuals had the least (4.17%). Married individuals had the highest seropositivity of 7.69%, while the divorced and widow/widower had 5.26% and 4.76% respectively. People who injected drugs recorded the highest seropositivity of 33.33%, with multiple sex partners at 6.90%, while people who shared sharp objects had the least (6.67%). There were no significant differences statistically in HCV seroprevalence among the different age categories, gender, tribe, education, occupation, marital and risk factors (p>0.05). The HCV prevalence rate (5.8%) observed in this study underscored the need to intensify HCV screening among people living with HIV/AIDS for early diagnosis and management of cases.
Downloads
References
Advisory Committee on Immunization Practice (ACIP) (1990). Protection against viral hepatitis: Recommendations of the immunization practices advisory committee. Morbidity and Mortality Weekly Report, 39, 39-42.
Adekunle, A. E., Oladimeji, A. A., Temi, A. P., Adeseye, A. I., Akinyeye, O. A., & Taiwo, R. H. (2011). Baseline CD4+T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. Pan African Medical Journal, 9, 6. https://doi.org/10.4314/pamj.v9i1.71178
Adepoju, V. A., Chidubem, O., Adejumo, O., Inegbeboh, J., Kangiwa, U., Okafor, V., Okolie, J., Olanipekun, A. H., Ekerete, C., &Egbedeyi, F. (2018). International Journal of Advanced Multidisciplinary, 5(2), 11-19. ISSN: 2393-8870.
Adoga, M. P., Banwat, E. B., Forbi, J. C., Nimzing, L., Pam, C. R., &Gyar, S. D. (2009). Human immunodeficiency virus, hepatitis B virus and Hepatitis C virus: Seroprevalence, coinfection and risk factors among prison inmates in Nasarawa State, Nigeria. Journal of Infection in Developing Countries, 3, 539-547. https://doi.org/10.3855/jidc.472
Agwale, S. M., Tanimoto, L., & Womack, C. (2004). Prevalence of HCV coinfection in HIV infected individuals in Nigeria and characterization of HCV genotypes. Journal of Clinical Virology, 31, 3-6. https://doi.org/10.1016/j.jcv.2004.09.001
Alavi, S. M., & Etemadi, A. (2007). HIV/HBV, HIV/HCV and HIV/HTLV-1 coinfection among injection drug user patients hospitalized at the infectious disease ward of training hospital in Iran. Pakistan Journal of Medical Sciences, 23, 510-513.
Ali, V. O., Okolo, M. L. O., Omatola, C. A., Okoye, S. C., Ezemba, C. C., & Sani, J. U. (2024). Seroprevalence and coinfection of HBV, HCV, and HIV among patients visiting selected hospitals in Anyigba, Kogi State. Journal of Immunoassay and Immunochemistry, 1-14. https://doi.org/10.1080/15321819.2024.2349009
Aliyu, G. G., Aliyu, S. H., Ehoche, A., Dongarwar, D., Yusuf, R. A., Aliyu, M. H., & Salihu, H. M. (2021). The burden of HIV, Hepatitis B and Hepatitis C by armed conflict setting: the Nigeria aids indicator and impact survey, 2018. Annals of Global Health, 87(1). https://doi.org/10.5334/aogh.3226
Amin, J., Kaye, M., & Skidmore, S. (2004). HIV and Hepatitis C coinfection within the CAESAR study. HIV Medicine, 5, 174-179. https://doi.org/10.1111/j.1468-1293.2004.00207.x
Anigilage, E. A., &Olutola, A. (2013). Human Immunodeficiency Virus and Hepatitis C Virus Coinfections among Children in an Antiretroviral Therapy Programme in Benue, Nigeria. Internet Journal of Infectious Diseases, 12(1), 7. https://doi.org/10.1155/2013/932697
Balmasova, I. P., Malova, E. S., &Efratova, E. P. (2019). HIV infection and HIV/HCV co- infection problem. Russian journal of immunology, 22(2-1), 144-146. https://doi.org/10.31857/S102872210006430-8
Balogun, T. M., Emmanuel, S., &Ojerinde, E. F. (2012). HIV, Hepatitis B and C viruses’ coinfection among patients in a Nigerian tertiary hospital. Pan African Medical Journal, 12, 100.
Carmen, P., Sabrina, P., Ted, B., Karen, D., Barbara, R., & Rya, C. (2014). Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta. Canadian Journal of Infectious Diseases and Medical Microbiology, 25(1), 8–13. https://doi.org/10.1155/2014/971546
Chen, J. Y., Feeney, E. R., & Chung, R. T. (2014). HCV and HIV coinfection: mechanisms and management. Nature reviews Gastroenterology & hepatology, 11(6), 362-371. https://doi.org/10.1038/nrgastro.2014.17
Dimitrakopoulos, A., Takou, A., & Haida, A. (2000). The prevalence of hepatitis B and C in HIV positive Greek patients: relationship to survival of deceased AIDS patients. Journal of Infection, 40, 127-131. https://doi.org/10.1053/jinf.1998.0636
Eleje, G. U., Onubogu, C. U., Fiebai, P. O., Mbachu, I. I., Akaba, G. O., Loto, O. M., ... & Triplex Infection in Pregnancy Collaboration Group 1–36. (2022). Mother-to-child transmission of human immunodeficiency virus, hepatitis B virus and Hepatitis C virus among pregnant women with single, dual or triplex infections of human immunodeficiency virus, hepatitis B virus and Hepatitis C virus in Nigeria: a systematic review and meta-analysis. SAGE Open Medicine, . https://doi.org/10.1177/20503121221095411
Ellwanger, J. H., Leal, B. K., Valverde-Villegas, J. M., Simon, D., Marangon, C. G., Mattevi, V. S., ... & Chies, J. A. B. (2018). CCR5Δ32 in HCV infection, HCV/HIV coinfection, and HCV-related diseases. Infection, Genetics and Evolution, 59, 163-166. https://doi.org/10.1016/j.meegid.2018.02.002
Elrashdy, F., Hagag, S., Mohamed, R., Alem, S. A., Meshaal, S., Cordie, A., ... & Esmat, G. (2022). Incidence of Hepatitis C virus infection among people living with HIV: An Egyptian cohort study. Southern African Journal of HIV Medicine, 23(1). https://doi.org/10.4102/sajhivmed.v23i1.1442
Eze, E. U., Ofli, A. N., &Onunu, A. N. (2010). Prevalence of Hepatitis C virus in HIV infected persons in a tertiary hospital in Nigeria. Nigerian Journal of Clinical Practice, 13, 41-46.
Famoni O. P., Oyinloye, J. M. A., Okiki P. A., Daramola G. O., Ojerinde A. O. & Ajayi O. D. (2024). Prevalence of HBV Coinfections with HCV and HIV among Blood Donors in Ado-Ekiti, Ekiti State, Nigeria. Journal of Advances in Microbiology, 24(5), 6-17. https://doi.org/10.9734/jamb/2024/v24i5822
Forbi, J. C., Gabadi, S., Alabi, R., Iperepolu, H. O., Pam, C. R., &Enronu, P. E. (2007). The role of triple infection with Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus (HIV) Type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Memórias do Instituto Oswaldo Cruz, 102(4), 535–537. https://doi.org/10.1590/S0074-02762007005000025
Gebre, K. (2005). Hepatitis C virus and HIV coinfection among attendants of voluntary counseling and testing center, and HIV follow up clinics at Tikur Anbessa Hospital. Faculty of Medicine, Addis Ababa University.
Gedefie, A., Seid, A., Molla Fenta, G., Tilahun, M., Shibabaw, A., & Ali, A. (2023). Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross- sectional study. SAGE Open Medicine, 11,. https://doi.org/10.1177/20503121231166642
Gobran, S. T., Ancuta, P., & Shoukry, N. H. (2021). A tale of two viruses: immunological insights into HCV/HIV coinfection. Frontiers in immunology, 12, 726419. https://doi.org/10.3389/fimmu.2021.726419
Grzeszczuk, A., Wandalowicz, A. D., Jaroszewicz, J., &Flisiak, R. (2015). Prevalence and risk factors of HCV/HIV coinfection and HCV genotype distribution in North-Eastern Poland. Hepatitis Monthly, 15(7). https://doi.org/10.5812/hepatmon.27740v2
Hajizadeh, M., Binabaj, M. M., Asadi, A., Abdi, M., Shakiba, A., Beig, M., ... & Sholeh, M. (2024). Prevalence of HCV among patients with HIV in Iran: A systematic review and meta-analysis. Vacunas (English Edition), 25(1), 128-139. https://doi.org/10.1016/j.vacune.2024.02.014
Iannuzzella, F., Vaglio, A., &Garini, G. (2010). Management of Hepatitis C Virus-Related Mixed Cryoglobulinemia. American Journal of Medicine, 123(5), 400-408. https://doi.org/10.1016/j.amjmed.2009.09.038
Khamis, H. H., Farghaly, A. G., Shatat, H. Z., & El-Ghitany, E. M. (2016). Prevalence of Hepatitis C virus infection among pregnant women in a rural district in Egypt. Infectious Diseases in Obstetrics and Gynecology, 46, 21-27. https://doi.org/10.1177/0049475514561330
Kim, S., Hu, J., & Gautom, R. (2007). HIV and Hepatitis C virus coinfection, Cameroon. Emerging Infectious Diseases, 13, 248-260.
Li, F., Feng, Y., Liu, X., Hao, J., Wang, D., Hu, H., ... & Xing, H. (2024). HBV and HCV Co- Infection in Chinese Newly Diagnosed HIV+ Subjects in 2015 and 2023: A Cross- Sectional Study. Pathogens, 13(5), 367. https://doi.org/10.3390/pathogens13050367
Mboto, C. I., Fielder, M., Russell, A., & Jewell, A. P. (2009). Prevalence of HIV-1, HIV-2, Hepatitis C and Coinfection in the Gambia. West African Journal of Medicine, 28, 306- 309. https://doi.org/10.4314/wajm.v28i1.48418
Meisel, H., Reip, A., & Faltus, B. (1995). Transmission of Hepatitis C Virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet, 345, 1209-1211. https://doi.org/10.1016/S0140-6736(95)91992-9
Murphy, D. G., Willems, B., Deschênes, M., Hilzenrat, N., Mousseau, R., & Sabbah, S. (2007). Use of sequence analysis of the NS5B region for routine genotyping of Hepatitis C virus with reference to C/E1 and 5 untranslated region sequences. Journal of Clinical Microbiology, 45(4), 1102–1112. https://doi.org/10.1128/JCM.02366-06
National Population Commission (2017).
Nneoma, C. J. A., Peace, T. S., & Miracle, H. M. (2019). Viral hepatitis B and C coinfection with Human Immunodeficiency Virus among adult patients attending selected highly active antiretroviral therapy clinics in Nigeria’s capital. Journal of Immunoassay and Immunochemistry.
Nnewi, E. (2011). Prevalence of Hepatitis C viral infection in pregnant women. Journal of Gynecology and Obstetrics, 15(1), 2640-2501.
Nwalozie, R., Kareem, J. A., &Ikpo, P. E. (2024). Epidemiological Distribution of Human Immunodeficiency Virus (HIV) among Residents of Port Harcourt Metropolis in Rivers State Nigeria. Asian Journal of Research in Infectious Diseases, 15(6), 1-11. https://doi.org/10.9734/ajrid/2024/v15i6350
Nwankiti, O. O., Ejekwolu, A. J., &Ndako, A. J. (2012). A survey for antibodies to Hepatitis C virus among women of childbearing age. Nature and Science, 10(9), 148-152.
Ojide, C. K., Kalu, E. I., Ogbaini-Emevon, E., & Nwadike, V. U. (2015). Coinfections of HBV, HCV, and HIV. Nigerian Journal of Clinical Practice, 18(4), 519. https://doi.org/10.4103/1119-3077.151790
Okechukwu, N., Godwin, M., Eugenia, O., Desmond, E., & Patrick, O. (2014). The seroprevalence of Hepatitis B viral infection in HIV tested positive individuals in Owerri, Imo State, Nigeria. Journal of AIDS and Clinical Research. https://doi.org/10.4172/2155-6113.1000273
Okonko, I. O., Onwusor, H., Awanye, A. M., Cookey, T. I., Onoh, C. C., & Adewuyi-Oseni, S. (2020). Prevalence of Some Opportunistic Infections (OIs) and Coinfections among HIV-Infected Persons in Port Harcourt, Nigeria. South Asian J Res Microbiol, 8, 1-12. https://doi.org/10.9734/sajrm/2020/v8i130182
Okonkwo, U. C., Okpara, H., & Otu, A. (2017). Prevalence of hepatitis B, Hepatitis C and human immunodeficiency viruses, and evaluation of risk factors for transmission: Report of a population screening in Nigeria. South African Medical Journal, 107(4), 346-351. https://doi.org/10.7196/SAMJ.2017.v107i4.12198
Oluboyo, B. O., Ugochukwu, V. I., Oluboyo, A. O., Ihim, A. C., Chukwuma, G. O., Ogenyi, S. I., &Onyemelukwe, A. (2014). Prevalence of hepatitis B and C viral infection in pregnant women. European Scientific Journal, 10(3), 1857-7881.
Pearlman, B. L. (2006). Hepatitis C Virus infection in African Americans. Clinical Infectious Diseases, 42(1), 82-91. https://doi.org/10.1086/498512
Piekarska, A., Berkan-Kawińska, A., Berak, H., Mazur, W., Sitko, M., Parfieniuk-Kowerda, A., ... &Flisiak, R. (2024). Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients. Expert Review of Anti-Infective Therapy, 1–6. https://doi.org/10.1080/14787210.2024.2353691
Platt, L., Easterbrook, P., Gower, E., McDonald, B., Sabin, K., McGowan, C., ... & Vickerman, P. (2016). Prevalence and burden of HCV coinfection in people living with HIV: a global systematic review and meta-analysis. The Lancet infectious diseases, 16(7), 797- 808. https://doi.org/10.1016/S1473-3099(15)00485-5
Rourke, S. B., Gardner, S., Burchell, A. N., Raboud, J., Rueda, S., & Bayoumi, A. M. (2012). Cohort Profile: The Ontario HIV Treatment Network Cohort Study (OCS). International Journal of Epidemiology, 6(1).
Rusine, J., Ondoa, P., Asiimwe Kateera, B., Boer, K. R., Uwimana, J. M., &Mukabayire, O. (2013). High seroprevalence of HBV and HCV infection in HIV infected adults in Kigali, Rwanda. PLoS One, 8, e63303. https://doi.org/10.1371/journal.pone.0063303
Ryan, K. J., & Ray, C. G. (2004). Sherris Medical Microbiology (4th ed.). McGraw-Hill.
Ryscavage, P., Hussien, S., Seung, H., &Hynicka, L. (2024). CD4+ T‐cell recovery in HIV/Hepatitis C co‐infected patients following successful Hepatitis C treatment. HIV medicine. https://doi.org/10.1111/hiv.13612
Sulkowski, M. S. (2016). HCV‐HIV co‐infected patients: no longer a ‘special’population?. Liver International, 36, 43-46. https://doi.org/10.1111/liv.13021
Thomadakis, C., Basoulis, D., Tsachouridou, O., Protopapas, K., Paparizos, V., Astriti, M., ... & Touloumi, G. (2024). HCV Cascade of Care in HIV/HCV Co-Infected Individuals: Missed Opportunities for Micro-Elimination. Viruses, 16(6), 885. https://doi.org/10.3390/v16060885
Thrusfield, M. (1997). Statistics in epidemiology: Methods, techniques, and applications. Preventive Veterinary Medicine, 1(32), 149-151. https://doi.org/10.1016/S0167-5877(97)00003-2
Tripathi, A. K., Khanna, M., & Gupta, N. (2007). Low prevalence of HBV and HCV co- infection in patients with HIV in Northern India. Journal of the Association of Physicians of India, 55, 429-431.
Umolu, P. I., Okoror, E. L., &Orhue, P. (2005). HIV seropositivity and HBsAg among blood donors in Benin City, Edo State, Nigeria. African Health Sciences, 5(1), 55-58.
Verucchi, G., Calza, L., & Manfredi, R. (2004). HIV and HCV coinfection: Epidemiology, natural history, therapeutic options, and clinical management. Infection, 32, 33-46. https://doi.org/10.1007/s15010-004-3063-7
Walusansa, V., &Kagimu, M. (2009). Screening for Hepatitis C among HIV positive patients at Mulago Hospital in Uganda. African Health Sciences, 9, 143-146.
Williams, R. (2006). Global challenges in liver disease. Hepatology, 44(3), 521-526. https://doi.org/10.1002/hep.21347
World Health Organization. (2012). Viral Hepatitis Factsheet. http://www.who.int
Xia, X., Luo, J., Bai, J., & Yu, R. (2008). Epidemiology of HCV infection among injection drug users in China. Emerging Infectious Diseases, 122(10), 990-1003. https://doi.org/10.1016/j.puhe.2008.01.014
Ya’aba, Y., Isu, N. R., Onoja, A. J., Ibrahim, K., Mohammed, S. B., & Oladosu, P. (2015). Prevalence of Hepatitis C Virus (HCV) in healthy adults and Human Immunodeficiency Virus (HIV) infected persons in Abuja, Nigeria. Journal of Phytomedicines, 1(1), 11-23.
Yousefpouran, S., Mostafaei, S., Manesh, P. V., Iranifar, E., Bokharaei-Salim, F., Nahand, J. S., ... &Moghoofei, M. (2020). The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Coinfection and elite controllers for determination of biomarker. Microbial pathogenesis, 147, 104355. https://doi.org/10.1016/j.micpath.2020.104355
Yusuf-Ajibade, N., Ogunsina, M. A., Omisakin, O. O., Bello-Ovosi, B., Yakubu, P. D., & Sani, H. (2023). Knowledge of Hepatitis B and C among Clients Co-infected with Human Immunodeficiency Virus and Hepatitis B and C in a Tertiary Hospital in Kaduna, Northwest Nigeria. Journal of Epidemiological Society of Nigeria, 6(2), 52-58. https://jeson.org.ng/index.php/jeson/article/view/154
Zenebe, Y., Mulu, W., Yimer, M., & Abera, B. (2015). Seroprevalence and risk factors of Hepatitis C virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: Cross sectional study. Pan African Medical Journal, 21, 158. https://doi.org/10.11604/pamj.2015.21.158.6367
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
